摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2E)-3,4,5-trimethyl-2-(3,4,5-trimethyl-(213C)1,3-thiazol-2-ylidene)-(213C)1,3-thiazole | 134486-80-9

中文名称
——
中文别名
——
英文名称
(2E)-3,4,5-trimethyl-2-(3,4,5-trimethyl-(213C)1,3-thiazol-2-ylidene)-(213C)1,3-thiazole
英文别名
——
(2E)-3,4,5-trimethyl-2-(3,4,5-trimethyl-(213C)1,3-thiazol-2-ylidene)-(213C)1,3-thiazole化学式
CAS
134486-80-9
化学式
C12H18N2S2
mdl
——
分子量
256.398
InChiKey
WQZGHADAMGYLSA-TYBRUWTQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    16
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    57.1
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    氘代四氢呋喃 为溶剂, 生成 (2Z)-3,4,5-trimethyl-2-(3,4,5-trimethyl-(213C)1,3-thiazol-2-ylidene)-(213C)1,3-thiazole 、 (2E)-3,4,5-trimethyl-2-(3,4,5-trimethyl-(213C)1,3-thiazol-2-ylidene)-(213C)1,3-thiazole
    参考文献:
    名称:
    来自芳香N-杂环卡宾(苯并咪唑啉-2-基苯,噻唑啉-2-基苯)的Breslow中间体
    摘要:
    我们报道了衍生自芳香性N-杂环卡宾(NHC)的难以捉摸的Breslow中间体的第一代及其表征,即苯并咪唑啉-2-亚烷基(NMR,X射线分析)和噻唑啉-2-亚基(NMR)。在前一种情况下,二氨基烯醇是由游离的N,N-双(2,6-二异丙基苯基)和N,N-双(甲磺酰基)取代的苯并咪唑啉-2-亚烷基与醛反应而生成的。在后一种情况下,以3,4,5-三甲基噻唑啉-2-亚基为起始原料。第一个基于噻唑啉-2-亚丙基的Breslow中间体的明确NMR鉴定取决于NHC和醛组分的双13 C标记。通过与过量醛形成安息香来确认酰基阴离子的反应性。
    DOI:
    10.1002/anie.201801676
点击查看最新优质反应信息

文献信息

  • Reactivity of the thiazolium C2 ylide in aprotic solvents: novel experimental evidence for addition rather than insertion reactivity
    作者:Yao Tsung Chen、Frank Jordan
    DOI:10.1021/jo00017a010
    日期:1991.8
    Two thiazolium compounds were synthesized specifically labeled at their C2 positions: 3,4,5-trimethyl[2-C-13]thiazolium nitrate and 3-benzyl-5-(beta-ethoxyethyl)-4-methyl[2-C-13]thiazolium bromide, with a view to examine their pathways leading to dimerization in strongly basic medium using C-13 NMR. On addition of less than 1 equiv of base the N-methyl ion first formed an unsymmetrical dimer in which the C2 atoms of two molecules were bonded to each other and only one of them still carried a hydrogen; that unsymmetrical dimer upon addition of excess base lost the remaining hydrogen at C2 and was converted to a mixture of syn and anti symmetrical dimers in nearly equal amounts. The sequence of observations on addition of base to the N-methyl derivative is consistent with nucleophilic addition of the conjugate base to a second thiazolium ion at its C2 position. Since the unsymmetrical dimer is formed first, rather than the symmetrical dimer, the latter cannot result from direct dimerization of two conjugate bases (ylides) by a carbene mechanism. Instead, a carbanion-addition mechanism was further supported by two experiments. A ''crossover'' experiment was designed in which unsymmetrical dimers were detected in Me2SO on addition of limiting potassium tert-butoxide to thiazolium ions containing [2-C-13]-H and [2-C-12]-D, under conditions such that there was little H/D exchange observed at the C2 position. Also, N-3-alkenylthiazolium ions were synthesized, that, if carbenic reactivity had existed, would have resulted in formation of cyclopropanes. In preference to the intramolecular reaction, intermolecular unsymmetrical dimers resulted in each case, consistent with nucleophilic addition. On addition of base to the N-benzylthiazolium ion, the first product to be detected by C-13 NMR was the syn/anti symmetrical dimer mixture (again bonded via the C2 atoms), that underwent a [1,3]-sigmatropic rearrangement of one of the benzyl groups from N3 to C2. According to H-1 NMR recorded within minutes of mixing, the unsymmetrical dimer precedes the symmetrical one for this salt as well. The reactivity of the C2 ylide derived from the N-methyl and N-benzylthiazolium ions can be rationalized according to an ionic addition reaction, implying that the related thiamin (vitamin B1) conjugate base (ylide) behaves similarly.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)